Toward a Better Understanding of Bioassays for the Development of Biopharmaceuticals by Exploring the Structure-Antibody-Dependent Cellular Cytotoxicity Relationship in Human Primary Cells-Reference-Cited by-同舟云学术

Toward a Better Understanding of Bioassays for the Development of Biopharmaceuticals by Exploring the Structure-Antibody-Dependent Cellular Cytotoxicity Relationship in Human Primary Cells

Published:2020-10-29 Issue: Volume:11 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Wieckowski Sébastien,Avenal Cécile,Orjalo Arturo V.,Gygax Daniel,Cymer Florian

Funder

Roche

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference85 articles.

1. Points to consider in the manufacture and testing of monoclonal antibody products for human use (1997). U.S. Food and Drug Administration Center for Biologics Evaluation and Research,1997

2. Determination of critical quality attributes for monoclonal antibodies using quality by design principles;Alt;Biologicals,2016

3. Molecular and functional analysis of monoclonal antibodies in support of biologics development;Wang;Protein Cell,2018

4. NK cell-mediated antibody-dependent cellular cytotoxicity in cancer immunotherapy;Wang;Front Immunol,2015

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Label-free assessment of complement-dependent cytotoxicity of therapeutic antibodies via a whole-cell MALDI mass spectrometry bioassay;Scientific Reports;2024-09-13

2. Define Critical Parameters of Trastuzumab-Mediated ADCC Assays via Assay Optimization Processes, Focusing on the Impact of Cryopreserved Effector Cells on Assay Performance;Cancers;2024-06-27

3. Label-free Assessment of Complement-Dependent Cytotoxicity of Therapeutic Antibodies via a Whole-Cell MALDI Mass Spectrometry Bioassay;2024-05-05

4. Análisis del polimorfismo FcƴRIII en pacientes con cáncer de mama HER2+ en tratamiento neoadyuvante con Quimioterapia más trastuzumab y pertuzumab;Oncología Clínica;2023-09-18

5. Role of Fcγ receptors in HER2-targeted breast cancer therapy;Journal for ImmunoTherapy of Cancer;2022-01